Case of Stroke from Cerebral Vasculitis following Carfilzomib, Lenalidomide, and Dexamethasone Therapy in a Patient with Relapsing Multiple Myeloma

被引：4

作者：

Osafehinti, Deborah ^{[1
]}

Zivari, Kaveh ^{[1
]}

机构：

[1] Maimonides Hosp, Dept Internal Med, Brooklyn, NY 11219 USA

来源：

CASE REPORTS IN HEMATOLOGY | 2019年 / 2019卷

关键词：

DIAGNOSIS; SURVIVAL; RISK;

D O I：

10.1155/2019/5180424

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Lenalidomide, a synthetic derivation of thalidomide, in recent years, has been the backbone of multiple myeloma treatment leading to improved survival. Common adverse effects from lenalidomide-based regimens include hypertension, heart disease, and venous thromboembolism. Hence, thromboprophylaxis is recommended to reduce the risk of stroke. We report a case of stroke from cerebral vasculitis in a patient receiving carfilzomib, lenalidomide, and dexamethasone for relapsing multiple myeloma, not previously published. Medical oncologists should be aware of other causes of stroke among multiple myeloma patients receiving a lenalidomide-based regimen to prevent its occurrence.

引用

页数：4

共 20 条

[1] Unexpected Erythroid and Cytogenetic Responses After Discontinuation of a Short Course of Lenalidomide As a Result of Severe Skin Rash in a Patient With 5q Syndrome [J].

Breccia, Massimo ;

Cannella, Laura ;

Latagliata, Roberto ;

Loglisci, Giuseppina ;

Salaroli, Adriano ;

Santopietro, Michelina ;

Oliva, Esther N. ;

Alimena, Giuliana .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (14) :E402-E403

[2] Global Burden of Multiple Myeloma ASystematic Analysis for the Global Burden of Disease Study 2016 [J].

Cowan, Andrew J. ;

Allen, Christine ;

Barac, Aleksandra ;

Basaleem, Huda ;

Bensenor, Isabela ;

Curado, Maria Paula ;

Foreman, Kyle ;

Gupta, Rahul ;

Harvey, James ;

Hosgood, H. Dean ;

Jakovljevic, Mihajlo ;

Khader, Yousef ;

Linn, Shai ;

Lad, Deepesh ;

Mantovani, Lorenzo ;

Vuong Minh Nong ;

Mokdad, Ali ;

Naghavi, Mohsen ;

Postma, Maarten ;

Roshandel, Gholamreza ;

Shackelford, Katya ;

Sisay, Mekonnen ;

Cuong Tat Nguyen ;

Tung Thanh Tran ;

Bach Tran Xuan ;

Ukwaja, Kingsley Nnanna ;

Vollset, Stein Emil ;

Weiderpass, Elisabete ;

Libby, Edward N. ;

Fitzmaurice, Christina .

JAMA ONCOLOGY, 2018, 4 (09) :1221-1227

[3]

Cruz Martin P, 2016, P T, V41, P556

[4] Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement [J].

Dimopoulos, M. A. ;

Palumbo, A. ;

Attal, M. ;

Beksac, M. ;

Davies, F. E. ;

Delforge, M. ;

Einsele, H. ;

Hajek, R. ;

Harousseau, J-L ;

Leal da Costa, F. ;

Ludwig, H. ;

Mellqvist, U-H ;

Morgan, G. J. ;

San-Miguel, J. F. ;

Zweegman, S. ;

Sonneveld, P. .

LEUKEMIA, 2011, 25 (05) :749-760

[5] The Diagnosis and Treatment of Multiple Myeloma [J].

Gerecke, Christian ;

Fuhrmann, Stephan ;

Strifler, Susanne ;

Schmidt-Hieber, Martin ;

Einsele, Hermann ;

Knop, Stefan .

DEUTSCHES ARZTEBLATT INTERNATIONAL, 2016, 113 (27-28) :470-+

[6] Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy-Results of a Case Control Study [J].

Hinduja, Archana ;

Limaye, Kaustubh ;

Ravilla, Rahul ;

Sasapu, Appalnaidu ;

Papanikolaou, Xenofon ;

Wei, Lai ;

Torbey, Michel ;

Waheed, Sarah .

PLOS ONE, 2016, 11 (11)

[7]

Jewell Sarah, 2015, Fed Pract, V32, p49S

[8] Mechanism of action of lenalidomide in hematological malignancies [J].

Kotla, Venumadhav ;

Goel, Swati ;

Nischal, Sangeeta ;

Heuck, Christoph ;

Vivek, Kumar ;

Das, Bhaskar ;

Verma, Amit .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2009, 2

[9] Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes [J].

Landgren, O. ;

Iskander, K. .

JOURNAL OF INTERNAL MEDICINE, 2017, 281 (04) :365-382

[10] Cardiovascular Complications of Novel Multiple Myeloma Treatments [J].

Li, Weijuan ;

Cornell, R. Frank ;

Lenihan, Daniel ;

Slosky, David ;

Jagasia, Madan ;

Piazza, Gregory ;

Moslehi, Javid .

CIRCULATION, 2016, 133 (09) :908-912

← 1 2 →